Here is my (optimistic?) take on it. I guess if you think about it, if it "stops" working, then no point in continuing with the medication.
But if it continues to provide a slowing down or even improvement after 12 months, then wouldn't it be in everyone's interest (even the cynical) to keep this group going?
Market Data 
Markets 
AI
